Value of Interleukin 6 in Assessment of the Disease Severity in Patients with COVID-19 Infection without Preexisting Comorbidities - Egyptian Knowledge Bank - troweb

286343

Value of Interleukin 6 in Assessment of the Disease Severity in Patients with COVID-19 Infection without Preexisting Comorbidities

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Prognostic value of Procalcitonin and Interleukin 6 in COVID-19 patients

Article

Studying the role of Interleukin-6 (IL-6) and C-reactive protein (CRP) in Patients Infected with COVID-19 until Recovery

Article

Association between Interleukin 6 Serum Level and Severity of Disease among Pediatrics with Covid-19

Article

The Significance of Interleukin 6 in Predicting Severity of Covid -19 Infection in Egyptian Patients

Article

Assessment of the relation between IL-6 expression and the severity of covid-19 infection

Article

TNF-a and IL-10 Serum Levels in COVID-19 Patients and their Relation to Disease Severity

Article

C-reactive protein as an early marker of severity and outcome in patients with SARS-CoV-2 infection

Article

Serum Levels of Intercellular Adhesion Molecule-1 and TNF- in Patients with COVID-19 and Its Relation to Disease Severity

Article

C-Reactive Protein as a Prognostic Indicator in COVID-19 mild infection Patients

Article

Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity